Bibliography
- SLAMON DJ, CLARK GM, WONG SG et al.: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 235:177–182.
- http://www.asco.org ROMOND EH, PEREZ EA, BYANT J et al.: Doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab as adjuvant therapy for HER-2 positive operable breast cancer: combined analysis of NSABP-B31/NCCTG-N9831. Presented at the 2005 annual meeting of the American Society of Clinical Oncology, Orlando FL, USA (2005).
- http://www.asco.org PEREZ EA, SUMAN VJ, DAVIDSON N et al.: NCCTG N9831: May 2005 Update. Presented at the 2005 annual meeting of the American Society of Clinical Oncology, Orlando FL, USA (2005).
- http://www.asco.org PICCART-GEBHART MJ, ON BEHALF OF THE BREAST INTERNATIONAL GROUP (BIG) N-BpgisFH-LRL: First Results of the HERA Trial. Presented at the 2005 annual meeting of the American Society of Clinical Oncology, Orlando FL, USA (2005).